NEURO2022

Presentation information

Print

Symposia

[4S02m] Recent Advances of Gene Therapy for Neurological Disorders

Sun. Jul 3, 2022 9:00 AM - 11:00 AM Room 2 (Conference Building A1 (Okinawa Convention Center))

Chair: HIDEKI MOCHIZUKI, Stella Papa (Emory University School of Medicine and Yerkes National Primate Research Center)

[4S02m-02] Suitable combination of AAV capsid and cell type-specific promoter for effective gene therapy

*Hirokazu Hirai1,2 (1. Gunma Univ Grad Sch Med, Gunma, Japan, 2. Gunma Univ, Viral Vector Core, Gunma, Japan)

Keywords:AAV, Capsid, Promoter, Gene therapy

Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.

PW: Neuro2022

Password